Latest News

FDA grants orphan drug designation to ADV7103 for cystinuria
FDA grants orphan drug designation to ADV7103 for cystinuria

March 25th 2024

ADV7103 is currently being studied in the phase 2/3 CORAL-1 study, enrolling patients with cystinuria across centers in France and Belgium.

medical depiction of kidney stones
Alkaline water unlikely to prevent kidney stones, study finds

January 11th 2024

Top 10 kidney stone stories in 2023
Top 10 kidney stone stories in 2023

January 1st 2024

Microbiome alterations linked to kidney stone formation
Microbiome alterations linked to kidney stone formation

December 21st 2023

Thiazide diuretics lower risk of kidney stones, genetic proxies show
Thiazide diuretics lower risk of kidney stones, genetic proxies show

December 11th 2023

Video Series
Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.